Gemmus is a privately held pharmaceutical company focused on the development of innovative products for the treatment of infectious diseases by modulating the host response to the disease. Gemmus was founded in 2007 to develop EP2 and EP4 agonists for the treatment of influenza and in-licensed technology from a major pharmaceutical company. The company has applied for and received an SBIR(NIH) and a QTDP competitive grant. Gemmus is a member of the QB3 network, a San Francisco Bay Area life sciences incubator associated with the University of California - San Francisco (UCSF). The company is currently seeking suitable corporate partners for further clinical development of GP1681 and for expansion into additional viral indications.
View Top Employees from Gemmus Pharma| Website | http://www.gemmuspharma.com |
| Revenue | $8 million |
| Funding | $4.8 million |
| Employees | View employees |
| Founded | 2007 |
| Address | 409 Illinois St, San Francisco, California 94158, US |
| Phone | (415) 978-2151 |
| Industry | Biotechnology, Drug Stores & Pharmacies, Retail, Science and Engineering, Pharmaceuticals, Health Care, Pharmaceutical |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular Gemmus Pharma employee's phone or email?
Gemmus Pharma Questions
The Gemmus Pharma annual revenue was $8 million in 2024.
Gemmus Pharma is based in San Francisco, California.
The NAICS codes for Gemmus Pharma are [3254, 32541, 32, 325].
The SIC codes for Gemmus Pharma are [283, 28].
